413-203-6922
One of America’s Leading Providers of Deep Transcranial Magnetic Stimulation or dTMS
Dr. Zebrun is board-certified in adult, child, and adolescent psychiatry and is the Chief Psychiatric Officer at Achieve TMS East. He has been working in the field of Psychiatry for over 24 years. He received his medical degree from the University of Texas Southwestern Medical Center in Dallas. Dr. Zebrun is the psychiatrist at Achieve TMS East’s Amherst, Northampton, and Springfield MA offices.
Dr. Knapp is board-certified in adult, child, and adolescent psychiatry with over 25 years of experience working in the behavioral health field. Dr. Knapp is the psychiatrist at Achieve’s Leominster, Westborough, and Worcester MA offices.
Pamela A. Kurth, MD, MA, trained at Brown University for her residency/fellowship where she was Chief Resident and received her undergraduate degree in psychology locally from the University of Connecticut in Storrs, CT. Dr. Kurth is the psychiatrist at our West Hartford and Glastonbury CT offices.
Dr. Smith is the Chief Medical Officer for Achieve TMS East. He is a neurologist and sleep specialist. He received his medical degree from Albany Medical College. He completed his medical internship at Roger Williams Medical Center and his neurology training at Dartmouth Medical Center.
Deep TMS technology is similar to what is used in MRIs (magnetic resonance imaging systems). dTMS is widely tested, participating in over 60 clinical trials worldwide with registered patents by the U.S. National Institutes of Health (NIH).
The FDA has approved dTMS for the treatment of depression and OCD. FDA-approved depression and OCD treatments are administered by Certified Technicians.
TMS stands for transcranial magnetic stimulation, a non-invasive therapeutic treatment for depression and OCD using electromagnetic currents targeted to the prefrontal cortex of the brain, the mood regulation center.
Insurance accepted for treating Depression, specifically TMS therapy, has more than doubled in the last few years, a sign that insurance companies must see cost savings in a treatment method for major depressive disorder (MDD) that works more efficiently than the traditional regimen alone. Patients who continually suffer from the debilitating effects of medication-resistant depression may acquire other health conditions as a result, such as a substance abuse disorder or unhealthy weight gain, to name a few. The fact that more and more insurance companies are providing coverage for TMS indicates a cost benefit to the insurer, thus the broadening of benefits.
The following are some of the insurance plans currently working with Achieve TMS East: Aetna, BCBS, BMC, Cigna, Commonwealth Care Alliance, Fallon Health, GIC, Harvard Pilgrim, Husky, Masshealth PCC Plan, Medicare, Neighborhood Health Plan, One Care, Tricare, Tufts Health Plan, and United Health Care. If you don’t see your plan listed, please call and ask us about yours today.